Filing Details

Accession Number:
0001628280-24-001059
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-01-10 17:36:05
Reporting Period:
2024-01-08
Accepted Time:
2024-01-10 17:36:05
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1437402 Ardelyx Inc. ARDX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1611311 P. David Rosenbaum C/O Ardelyx, Inc.
400 Fifth Avenue, Suite 210
Waltham MA 02451
Chief Development Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-01-08 30,000 $6.64 286,596 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 113,293 Indirect By Wife
Common Stock 77,592 Indirect Family Trust
Footnotes
  1. Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on June 9, 2023.
  2. This transaction was executed in multiple trades in prices ranging from $6.46 to $7.00, inclusive. The price reported in Column 4 above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
  3. The shares are directly held by the Reporting Person's wife.
  4. The shares are directly held by David Paul Rosenbaum and Susan Edelstein Rosenbaum, Trustees of the David Paul Rosenbaum Family Trust.